Search Results 161-170 of 16327 for immunothérapie Bylaska
The goal of this study is to evaluate a new approach to immunotherapy in NHL by combining two antibodies, veltuzumab and epratuzumab. For treatment ...
Medicines used for this cancer include chemotherapy, immunotherapy and targeted therapy. The treatments your healthcare team chooses for you depend on your ...
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
T cells also are called T lymphocytes. Treatment for T-cell lymphomas may include a "watch and wait" approach, chemotherapy, immunotherapy, radiation therapy, ...
The purpose of this study is to evaluate the safety and tolerability of multiple subcutaneous injections of a mutanome-directed active immunotherapy (TG4050) in ...
Treatments for B-cell lymphomas may include immunotherapy, chemotherapy, radiation therapy, targeted therapy, CAR-T cell therapy and bone marrow transplant, ...
It is a type of antibody-drug conjugate. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, ...
Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers featured image. Arizona. Mayo Clinic ...
Immunotherapy in patients with autoimmune disease. J Thorac Dis. 2020 Nov ... Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysis.
The Immunometabolism and Cancer Immunology Lab of Marion R. Curtis, Ph.D., at Mayo Clinic studies the tumor microenvironment for ovarian cancer immunotherapy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.